Non-Submissions To England’s NICE Surge Across All Disease Areas

 
• By Leela Barham
  
Pink Sheet analysis examined the impact of the failure of companies to submit evidence to England's HTA body NICE. (Shutterstock)

More from United Kingdom

More from Market Access